scholarly journals Comparisons of insight in schizophrenia, bipolar I disorder, and depressive disorders with and without comorbid alcohol use disorder

2008 ◽  
Vol 62 (6) ◽  
pp. 685-690 ◽  
Author(s):  
Cheng-Fang Yen ◽  
Cheng-Chung Chen ◽  
Chung-Ping Cheng ◽  
Chia-Nan Yen ◽  
Huang-Chi Lin ◽  
...  
2019 ◽  
Vol 97 (8) ◽  
pp. 781-785 ◽  
Author(s):  
M.S. Zastrozhin ◽  
V.Y. Skryabin ◽  
V.V. Smirnov ◽  
E.A. Grishina ◽  
K.A. Ryzhikova ◽  
...  

The objective of the study was to investigate the effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder who received mirtazapine. The study included 109 Russian patients who received mirtazapine at a dose of 30.0 [15.0; 45.0] mg per day. Genotyping of CYP2D6*4 (1846G > A, rs3892097) was performed using real-time polymerase chain reaction with allele-specific hybridization. The activity of CYP2D6 was evaluated by determining the concentration of endogenous substrate of the enzyme and its urinary metabolite — pinoline to 6-hydroxy-1,2,3,4-tetrahydro-beta-carboline ratio, using high-performance liquid chromatography – mass spectrometry. The statistically significant differences between the scores on the Hamilton Depression Rating Scale (HAMD) in patients with different genotypes were revealed by day 16: (GG) 5.0 [3.0; 6.0], (GA) 1.5 [1.0; 3.2] (p < 0.001), and for the The UKU Side Effects Rating Scale (UKU): (GG) 6.0 [6.0; 7.0], (GA) 8.5 [8.0; 10.0] (p < 0.001). The calculation of correlation coefficients between the differences in scale scores and metabolic rate showed the presence of statistically significant weak inverse correlation with the efficacy indicator evaluated by HAMD (r = −0.278, p < 0.05), but not by UKU (r = 0.274, p > 0.05). This study demonstrated that an increased CYP2D6 activity reduces the efficacy of treatment with mirtazapine.


2016 ◽  
Vol 165 ◽  
pp. 283-287 ◽  
Author(s):  
Francesco Bartoli ◽  
Cristina Crocamo ◽  
Enrico Biagi ◽  
Francesco Di Carlo ◽  
Francesca Parma ◽  
...  

2011 ◽  
Vol 42 (4) ◽  
pp. 695-703 ◽  
Author(s):  
L. Boschloo ◽  
W. van den Brink ◽  
B. W. J. H. Penninx ◽  
M. M. Wall ◽  
D. S. Hasin

BackgroundPrevious studies suggest that alcohol-use disorder severity, defined by the number of criteria met, provides a more informative phenotype than dichotomized DSM-IV diagnostic measures of alcohol use disorders. Therefore, this study examined whether alcohol-use disorder severity predicted first-incident depressive disorders, an association that has never been found for the presence or absence of an alcohol use disorder in the general population.MethodIn a national sample of persons who had never experienced a major depressive disorder (MDD), dysthymia, manic or hypomanic episode (n=27 571), we examined whether a version of DSM-5 alcohol-use disorder severity (a count of three abuse and all seven dependence criteria) linearly predicted first-incident depressive disorders (MDD or dysthymia) after 3-year follow-up. Wald tests were used to assess whether more complicated models defined the relationship more accurately.ResultsFirst-incidence of depressive disorders varied across alcohol-use disorder severity and was 4.20% in persons meeting no alcohol-use disorder criteria versus 44.47% in persons meeting all 10 criteria. Alcohol-use disorder severity significantly predicted first-incidence of depressive disorders in a linear fashion (odds ratio 1.14, 95% CI 1.06–1.22), even after adjustment for sociodemographics, smoking status and predisposing factors for depressive disorders, such as general vulnerability factors, psychiatric co-morbidity and subthreshold depressive disorders. This linear model explained the relationship just as well as more complicated models.ConclusionsAlcohol-use disorder severity was a significant linear predictor of first-incident depressive disorders after 3-year follow-up and may be useful in identifying a high-risk group for depressive disorders that could be targeted by prevention strategies.


2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S84-S85
Author(s):  
Nanna Weye ◽  
Natalie Momen ◽  
Maria Christensen ◽  
Kim Iburg ◽  
John McGrath ◽  
...  

Abstract Background The Global Burden of Disease (GBD) study uses Years of Life Lost (YLLs) to quantify premature mortality. This is a useful metric from many perspectives, however because GBD acknowledges only a small number of mental disorders as causes of death (CoDs), the true impact of mental disorders on premature mortality is underestimated. Recently, methods have been introduced that compare people with a disorder to the general population by estimating Life Years Lost (LYLs). The aim of this study was to present register-based estimates of both YLLs and LYLs related to mental disorders. Methods We used nationwide registers to examine a cohort of all 6,989,627 people aged 0–94 years living in Denmark in 2000–2015. Using the GBD approved set of mental health-related CoDs (eating disorders, drug use disorders, alcohol use disorder and suicide), YLLs were estimated. In addition, we calculated all-cause and cause-specific differences in life expectancy after a mental disorder diagnosis as excess LYLs between those with a specific mental disorder and the age- and sex-matched general Danish population. The disorders of interest were alcohol use disorder, drug use disorders, schizophrenia, bipolar disorders, depressive disorders, anxiety disorders, eating disorders, personality disorders, developmental intellectual disability, autism spectrum disorders, ADHD and conduct disorder. Excess LYLs related to counts of comorbid mental disorders were also examined (i.e. those diagnosed with at least two, three or four disorders). Results Alcohol use disorder and suicide were the leading causes of YLLs (alcohol use disorder: Men 568.7 YLLs, women 155.5 YLLs per 100,000 person-years; suicide: Men 590.1 YLLs, women 202.3 YLLs per 100,000 person-years). However, all mental disorders were associated with shorter life expectancies using LYLs. Men and women diagnosed with any mental disorder had 11.22 (95% CI 11.09; 11.35) and 7.89 (95% CI 7.76; 8.01) years shorter life expectancies respectively, and the difference increased in those with comorbid mental disorders. Drug use disorders were associated with the largest excess LYLs (17.99 (95% CI 17.49; 18.53) in men and 15.29 (95% CI 14.70; 15.88) in women), however common disorders such as depressive disorders and anxiety disorders were also associated with substantive premature mortality (e.g. in men, 8.27 and 7.52 LYLs, respectively). Schizophrenia was associated with 13.80 (95% CI 13.47; 14.14) excess LYLs in men and 11.77 (95% CI 11.38; 12.13) in women. Discussion Register-based studies allow the calculation of precise individual YLLs and LYLs. The novel LYL metric seems to better capture the true impact of mental disorders on premature mortality and also facilitates the exploration of comorbidity and specific CoDs in those with mental disorders.


2020 ◽  
Author(s):  
Sawitri Assanangkornchai ◽  
Jiraluck Nontarak ◽  
Wichai Aekplakorn ◽  
Suwat Chariyalertsak ◽  
Pattapong Kessomboon ◽  
...  

Abstract Purpose Previous evidence indicates significant associations between alcohol-use disorders (AUD) and depressive disorders and their strong links with social conditions. This study aims to investigate the association between AUD and major depressive episode (MDE) across various socio-economic groups. Methods Data from the 2014 Thai National Health Examination Survey was obtained containing a random sample of 13,177 adults aged > 20 years from the whole population. The Alcohol-Use Disorders Identification Test (AUDIT) was used to classify respondents into non-problem, hazardous drinking (score 8-15) and harmful-dependent drinking (score 16-40). MDE was identified using questions based on the DSM-IV. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) were calculated using logistic regression to determine the strength of associations. Results The prevalence of hazardous, harmful-dependent drinking and MDE was 10.3%, 1.9% and 2.5%, respectively. The association between MDE and AUD was modified by education level, wealth index and area of residence, with education having the largest effect (AOR=1.23, 95% CI: 0.55, 2.76 among those completing primary school only and AOR=15.19, 95% CI: 9.5, 24.29 among those completing secondary school or higher). Conclusion Socio-economic factors modify the association between alcohol-use disorder and depressive disorder among Thai people.


Author(s):  
Silke Behrendt ◽  
Barbara Braun ◽  
Randi Bilberg ◽  
Gerhard Bühringer ◽  
Michael Bogenschutz ◽  
...  

Abstract. Background: The number of older adults with alcohol use disorder (AUD) is expected to rise. Adapted treatments for this group are lacking and information on AUD features in treatment seeking older adults is scarce. The international multicenter randomized-controlled clinical trial “ELDERLY-Study” with few exclusion criteria was conducted to investigate two outpatient AUD-treatments for adults aged 60+ with DSM-5 AUD. Aims: To add to 1) basic methodological information on the ELDERLY-Study by providing information on AUD features in ELDERLY-participants taking into account country and gender, and 2) knowledge on AUD features in older adults seeking outpatient treatment. Methods: baseline data from the German and Danish ELDERLY-sites (n=544) were used. AUD diagnoses were obtained with the Mini International Neuropsychiatric Interview, alcohol use information with Form 90. Results: Lost control, desired control, mental/physical problem, and craving were the most prevalent (> 70 %) AUD-symptoms. 54.9 % reported severe DSM-5 AUD (moderate: 28.2 %, mild: 16.9 %). Mean daily alcohol use was 6.3 drinks at 12 grams ethanol each. 93.9 % reported binging. More intense alcohol use was associated with greater AUD-severity and male gender. Country effects showed for alcohol use and AUD-severity. Conclusion: European ELDERLY-participants presented typical dependence symptoms, a wide range of severity, and intense alcohol use. This may underline the clinical significance of AUD in treatment-seeking seniors.


Sign in / Sign up

Export Citation Format

Share Document